Literature DB >> 25675528

Dysregulation of Escherichia coli α-hemolysin expression alters the course of acute and persistent urinary tract infection.

Kanna Nagamatsu1, Thomas J Hannan2, Randi L Guest3, Maria Kostakioti1, Maria Hadjifrangiskou4, Jana Binkley1, Karen Dodson1, Tracy L Raivio3, Scott J Hultgren5.   

Abstract

Urinary tract infections (UTIs) are among the most common bacterial infections, causing considerable morbidity in females. Infection is highly recurrent despite appropriate antibiotic treatment. Uropathogenic Escherichia coli (UPEC), the most common causative agent of UTIs, invades bladder epithelial cells (BECs) and develops into clonal intracellular bacterial communities (IBCs). Upon maturation, IBCs disperse, with bacteria spreading to neighboring BECs to repeat this cycle. This process allows UPEC to gain a foothold in the face of innate defense mechanisms, including micturition, epithelial exfoliation, and the influx of polymorphonuclear leukocytes. Here, we investigated the mechanism and dynamics of urothelial exfoliation in the early acute stages of infection. We show that UPEC α-hemolysin (HlyA) induces Caspase-1/Caspase-4-dependent inflammatory cell death in human urothelial cells, and we demonstrate that the response regulator (CpxR)-sensor kinase (CpxA) two-component system (CpxRA), which regulates virulence gene expression in response to environmental signals, is critical for fine-tuning HlyA cytotoxicity. Deletion of the cpxR transcriptional response regulator derepresses hlyA expression, leading to enhanced Caspase-1/Caspase-4- and NOD-like receptor family, pyrin domain containing 3-dependent inflammatory cell death in human urothelial cells. In vivo, overexpression of HlyA during acute bladder infection induces more rapid and extensive exfoliation and reduced bladder bacterial burdens. Bladder fitness is restored fully by inhibition of Caspase-1 and Caspase-11, the murine homolog of Caspase-4. Thus, we have discovered that fine-tuning of HlyA expression by the CpxRA system is critical for enhancing UPEC fitness in the urinary bladder. These results have significant implications for our understanding of how UPEC establishes persistent colonization.

Entities:  

Keywords:  microbial pathogenesis; persistent colonization; urinary tract infection; uropathogenic E. coli

Mesh:

Substances:

Year:  2015        PMID: 25675528      PMCID: PMC4345586          DOI: 10.1073/pnas.1500374112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  66 in total

1.  Uropathogenic Escherichia coli flagella aid in efficient urinary tract colonization.

Authors:  Kelly J Wright; Patrick C Seed; Scott J Hultgren
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

2.  Novel three-dimensional organoid model for evaluation of the interaction of uropathogenic Escherichia coli with terminally differentiated human urothelial cells.

Authors:  Yarery C Smith; Kerian K Grande; Susan B Rasmussen; Alison D O'Brien
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

3.  Alpha-hemolysin contributes to the pathogenicity of piliated digalactoside-binding Escherichia coli in the kidney: efficacy of an alpha-hemolysin vaccine in preventing renal injury in the BALB/c mouse model of pyelonephritis.

Authors:  P O'Hanley; G Lalonde; G Ji
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

Review 4.  Virulence factors in Escherichia coli urinary tract infection.

Authors:  J R Johnson
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

5.  Caspase-11 promotes the fusion of phagosomes harboring pathogenic bacteria with lysosomes by modulating actin polymerization.

Authors:  Anwari Akhter; Kyle Caution; Arwa Abu Khweek; Mia Tazi; Basant A Abdulrahman; Dalia H A Abdelaziz; Oliver H Voss; Andrea I Doseff; Hoda Hassan; Abul K Azad; Larry S Schlesinger; Mark D Wewers; Mikhail A Gavrilin; Amal O Amer
Journal:  Immunity       Date:  2012-05-31       Impact factor: 31.745

6.  Interleukin-6 and interleukin-8 in serum and urine in patients with acute pyelonephritis in relation to bacterial-virulence-associated traits and renal function.

Authors:  S H Jacobson; B Hylander; B Wretlind; A Brauner
Journal:  Nephron       Date:  1994       Impact factor: 2.847

7.  Effect of Escherichia coli alpha-hemolysin on human peripheral leukocyte function in vitro.

Authors:  S J Cavalieri; I S Snyder
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

8.  Constitutive and inducible green fluorescent protein expression in Bartonella henselae.

Authors:  A K Lee; S Falkow
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

9.  Use of zebrafish to probe the divergent virulence potentials and toxin requirements of extraintestinal pathogenic Escherichia coli.

Authors:  Travis J Wiles; Jean M Bower; Michael J Redd; Matthew A Mulvey
Journal:  PLoS Pathog       Date:  2009-12-18       Impact factor: 6.823

10.  Lambda Red-mediated recombinogenic engineering of enterohemorrhagic and enteropathogenic E. coli.

Authors:  Kenan C Murphy; Kenneth G Campellone
Journal:  BMC Mol Biol       Date:  2003-12-13       Impact factor: 2.946

View more
  55 in total

Review 1.  Innate Immune Responses to Bladder Infection.

Authors:  Byron W Hayes; Soman N Abraham
Journal:  Microbiol Spectr       Date:  2016-12

2.  Evaluation of CpxRA as a Therapeutic Target for Uropathogenic Escherichia coli Infections.

Authors:  Lana Dbeibo; Julia J van Rensburg; Sara N Smith; Kate R Fortney; Dharanesh Gangaiah; Hongyu Gao; Juan Marzoa; Yunlong Liu; Harry L T Mobley; Stanley M Spinola
Journal:  Infect Immun       Date:  2018-02-20       Impact factor: 3.441

3.  Group B streptococcus exploits vaginal epithelial exfoliation for ascending infection.

Authors:  Jay Vornhagen; Blair Armistead; Verónica Santana-Ufret; Claire Gendrin; Sean Merillat; Michelle Coleman; Phoenicia Quach; Erica Boldenow; Varchita Alishetti; Christina Leonhard-Melief; Lisa Y Ngo; Christopher Whidbey; Kelly S Doran; Chad Curtis; Kristina M Adams Waldorf; Elizabeth Nance; Lakshmi Rajagopal
Journal:  J Clin Invest       Date:  2018-04-09       Impact factor: 14.808

Review 4.  Urinary tract infections: microbial pathogenesis, host-pathogen interactions and new treatment strategies.

Authors:  Roger D Klein; Scott J Hultgren
Journal:  Nat Rev Microbiol       Date:  2020-02-18       Impact factor: 60.633

5.  Infection: Dysregulation of E. coli α-hemolysin alters UTI course.

Authors:  Annette Fenner
Journal:  Nat Rev Urol       Date:  2015-03-03       Impact factor: 14.432

Review 6.  The Double Life of Group B Streptococcus: Asymptomatic Colonizer and Potent Pathogen.

Authors:  Blair Armistead; Elizabeth Oler; Kristina Adams Waldorf; Lakshmi Rajagopal
Journal:  J Mol Biol       Date:  2019-01-31       Impact factor: 5.469

Review 7.  The multiple antibacterial activities of the bladder epithelium.

Authors:  Jianxuan Wu; Yuxuan Miao; Soman N Abraham
Journal:  Ann Transl Med       Date:  2017-01

Review 8.  Immunity to uropathogens: the emerging roles of inflammasomes.

Authors:  Claire Hamilton; Lionel Tan; Thomas Miethke; Paras K Anand
Journal:  Nat Rev Urol       Date:  2017-03-07       Impact factor: 14.432

9.  Association of O-Antigen Serotype with the Magnitude of Initial Systemic Cytokine Responses and Persistence in the Urinary Tract.

Authors:  Dennis J Horvath; Ashay S Patel; Ahmad Mohamed; Douglas W Storm; Chandra Singh; Birong Li; Jingwen Zhang; Stephen A Koff; Venkata R Jayanthi; Kevin M Mason; Sheryl S Justice
Journal:  J Bacteriol       Date:  2016-01-11       Impact factor: 3.490

Review 10.  The nature of immune responses to urinary tract infections.

Authors:  Soman N Abraham; Yuxuan Miao
Journal:  Nat Rev Immunol       Date:  2015-09-21       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.